Panel Discussion: Integrating the Cardio-Kidney-Metabolic Continuum to Select Endpoints That Reflect What Matters Most to Patients

• Reconsidering whether kidney endpoints remain the most meaningful outcomes in CKD populations
• Assessing cardiovascular morbidity and mortality as increasingly relevant development endpoints
• Designing clinical programs capable of navigating overlapping renal, cardiovascular and metabolic disease

Speakers:

Matthias Kretzler

Professor of Medicine

University of Michigan

Anthony Gucciardo

Senior VP, Strategic Partnerships

National Kidney Foundation

Rajinder Khunkhun

Independent Consultant

HW Placeholder Bucket Account

Bergur Stefansson

Principal Director & Expert - Medical, Disease, Cardiovascular, Renal & Metabolism

Roche